ArticleActa pharmaceutica Sinica. B2024

High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionation.

Yu Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.